Suchergebnisse - "Bode, Bruce"

PubPharm (310)

1

Continuous and Intermittent Glucose Monitoring in 2023

enthalten in: Diabetes technology & therapeutics | 2024

von Dovc, K. | Bode, B. | Battelino, T.

2

Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod® 5 Automated Insulin Delivery System

enthalten in: Diabetes technology & therapeutics | 2024

von DeSalvo, D. | Bode, B. | Forlenza, G. | +8

3

Two Years with a Tubeless Automated Insulin Delivery System : A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes

enthalten in: Diabetes technology & therapeutics | 2024

von Criego, A. | Carlson, A. | Brown, S. | +18

4

Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes

enthalten in: The New England journal of medicine | 2023

von Ramos, E. | Dayan, C. | Chatenoud, L. | +109

5

Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2023

von Bergenstal, R. | Bode, B. | Bhargava, A. | +3

6

Publisher Correction : Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial

enthalten in: Nature medicine | 2023

von Pettus, J. | Boeder, S. | Christiansen, M. | +13

ErratumFor: Nat Med. 2022 Oct;28(10):2092-2099. - PMID 36192552

7

Safety and Glycemic Outcomes During the MiniMedTM Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes

enthalten in: Diabetes technology & therapeutics | 2023

von Pihoker, C. | Shulman, D. | Forlenza, G. | +56

8

Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5) : A Randomized Trial

enthalten in: Annals of internal medicine | 2023

von Bajaj, H. | Aberle, J. | Davies, M. | +6

ErratumIn: Ann Intern Med. 2023 Nov 7;:. - PMID 37931272

9

Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes

enthalten in: Diabetes therapy | 2023

von Bergenstal, R. | Bode, B. | Bhargava, A. | +3

10

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2) : a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Garvey, W. | Frias, J. | Jastreboff, A. | +94

CommentIn: Lancet. 2023 Aug 19;402(10402):586-588. - PMID 37385274

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]